Intuitive Surgical Inc

ISRG is in a Stage 3 distribution phase, with price tracing lower highs and lower lows beneath declining EMAs and no mean-reversion triggers. The medium-term bias is bearish, reinforced by the active Lower Highs & Lower Lows pattern signaling supply dominance. Short-term price is currently above the 9/20 EMAs without clear exhaustion, so execution should be deferred until rallies into the EMA/50-SMA cluster provide structurally favorable entry. The long-term downtrend remains intact below the 200-day SMA.

• ↑85% of Q2 revenue from instruments and services on 13K installed systems.
• ↑FDA clearance of new gastrointestinal robotic system expands addressable market.
• ↓da Vinci 5 platform rollout risks supply-chain execution and gross margin dilution.